心房颤动合并心力衰竭的心率控制  

Rate Control in Patients with Atrial Fibrillation and Heart Failure

作　　者：刘心遥[1] 李洁[1] LIU Xin-yao;LI Jie(Cardiovascular Center,Beijing Tongren Hospital,Capital Medical University,Beijing 100730,China)

机构地区：[1]首都医科大学附属北京同仁医院心血管中心,北京市100730

出　　处：《中国分子心脏病学杂志》2020年第3期3429-3432,共4页Molecular Cardiology of China

摘　　要：心房颤动(房颤)和心力衰竭(心衰)是临床常见的两种心血管疾病,且常合并存在。对于房颤合并心衰患者,心率控制非常重要。然而,此类患者心率控制目标尚有争议。在心率控制方式方面,无论是药物治疗还是器械治疗均有其特殊性。Atrial fibrillation(AF)and heart failure(HF)are both common cardiovascular diseases in clinical practice and they often coexist.Heart rate control is of great importance in patients with AF and HF.However,the target of rate control in such patients is still controversial.Drugs for rate control may have special characteristics in patients with AF and HF.And device treatment can be carried out in specific patients.

关 键 词：心房颤动 心力衰竭 心率控制 

分 类 号：R541.75[医药卫生—心血管疾病] R541.6[医药卫生—内科学]